United States Cytomegalovirus (CMV) Infection Epidemiology Insights 2013-2017 & 2023 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Cytomegalovirus (CMV) Infection - Epidemiology Insights - 2023 - United States" report to their offering.

This report provides an overview of the disease and the historical and forecasted epidemiological data of the Cytomegalovirus (CMV) Infection for the United States for 2013 - 2023.

The report considers the transplant patients, HIV patients and Infants under high risk for CMV infections and epidemiology forecast for these high risk categories have also been taken into consideration. Out of all these high risk categories, CMV is more prevalent among the Transplant patients than HIV patients and Infants. As per our estimation, the total number of Diagnosed CMV Infection cases in United States is expected to increase at a CAGR of 0.041% to 77,726 cases in 2023.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by our team of industry experts.

Scope:

  • Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
  • Identifying patient populations in the United States Cytomegalovirus (CMV) Infection market.
  • The Report covers the detailed historical and forecasted epidemiological data covering United States from 2013 - 2023.

Key Topics Covered:

  1. Disease Overview
  2. Symptoms of cytomegalovirus (CMV) Infection
  3. Etiology
  4. Risk Factors
  5. Pathogenesis of human cytomegalovirus
  6. Pathophysiology of cytomegalovirus infection
  7. Diagnosis
  8. Epidemiology and Patient Population
  9. United States
  10. Total CMV Prevalent, Diagnosed and Treatable Cases: Historical Data (2013-2015)
  11. Total CMV Prevalent, Diagnosed and Treatable Cases: Forecasted Data (2016-2023)
  12. CMV Patients among Transplants: Historical Data (2013-2015)
  13. CMV Patients among Transplants: Forecasted Data (2016-2023)
  14. Infants Patients at High Risk of CMV: Historical Data (2013-2015)
  15. Infants Patients at High Risk of CMV: Forecasted Data (2016-2023)
  16. HIV Patients at High Risk of CMV: Historical Data (2013-2015)
  17. HIV Patients at High Risk of CMV: Forecasted Data (2016-2023)
  18. Unmet Medical Needs
  19. Appendix

For more information about this report visit http://www.researchandmarkets.com/research/zr7x9g/cytomegalovirus

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Diseases Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Diseases Drugs